---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

For a complete and up-to-date list, see my [PubMed profile](https://pubmed.ncbi.nlm.nih.gov/?term=YourNameHere).  

---

### Statistical Methods  

- **Malatesta S**, Jacobson KR, Horsburgh CR, Carney T, Farhat M, Gile KJ, Kolaczyk ED, White LF. An Integrated Data-Driven Model for Clinical Phenotyping of Tuberculosis Disease Severity. Under review. 
- **Malatesta S**, Jacobson KR, Carney T, Kolaczyk ED, Gile KJ, White LF. Inferring bivariate association with continuous data from a respondent-driven sample. Journal of the Royal Statistical Society Series C: Applied Statistics. 2025;74(2):429-446. doi:10.1093/jrsssc/qlae061
- **Malatesta S**, Weir IR, Weber SE, Bouton TC, Carney T, Theron D, Myers B, Horsburgh CR, Warren RM, Jacobson KR, White LF. Methods for handling missing data in serially sampled sputum specimens for mycobacterial culture conversion calculation. BMC Med Res Methodol. 2022;22(1):297. doi:10.1186/s12874-022-01782-8

---

### Applied Infectious Disease Research  

- **Malatesta S**, Carney T, Niemand N, Theron D, Ratangee F, Meade C, Overbeck V, Weber SE, Horsburgh CR, White LF, Warren RM, Jacobson KR. Tuberculosis Disease Prevalence Among People Who Smoke Illicit Drugs: A Respondent-Driven Sampling Study in the Western Cape, South Africa. https://dx.doi.org/10.2139/ssrn.5010346. Journal of Infectious Diseases. In revision. 
- Niemand N*, Rooney JA*, **Malatesta S**, Rawoot N, Bouton TB, Ragan EJ, Carney T, White LF, Farhat M, Horsburgh CR, Myers B, Warren RM, Jacobson KR. Contamination rates in serially sampled sputum specimens obtained during tuberculosis treatment to capture culture conversion. Microbiology Spectrum. 2025;0(0):e00969-25. doi:10.1128/spectrum.00969-25 
- Tzelios C, **Malatesta S**, Carney T, White LF, Weber SE, Theron D, Myers B, Parry CDH, Warren RM, Horsburgh CR, Jacobson KR*, Farhat M*.Patient determinants and effects on adherence of adverse drug reactions to tuberculosis treatment: a prospective cohort analysis. Clinical Infectious Diseases. 2025:ciae642. doi:10.1093/cid/ciae642
- Overbeck V, **Malatesta S**, Carney T, Myers B, Parry CDH, Horsburgh CR, Theron D, White LF, Warren RM, Jacobson KR, Bouton TC. Understanding the impact of pandemics on long-term medication adherence: directly observed therapy in a tuberculosis treatment cohort pre- and post-COVID-19 lockdowns. BMC Infect Dis. 2024;24(1):1154. doi:10.1186/s12879-024-09994-7
- Wijk M, Gausi K, **Malatesta S**, Weber SE, Court R, Myers B, Carney T, Parry CDH, Horsburgh CR, White LF, Wiesner L, Warren RM, Uren C, McIlleron H, Kloprogge F, Denti P, Jacobson KR. The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. Journal of Antimicrobial Chemotherapy. 2024;79(8):2022-2030. doi:10.1093/jac/dkae206
- Myers B, Carney T, Rooney J, **Malatesta S**, Ragan EJ, White LF, Natcheva H, Bouton TC, Weber SE, Farhat M, McIlleron H, Theron D, Parry CDH, Horsburgh CR, Warren RM, Jacobson KR. Smoked drug use in patients with TB is associated with higher bacterial burden. Int J Tuberc Lung Dis. 2023;27(6):444-450. doi:10.5588/ijtld.22.0650
- Myers B, Carney T, Rooney J, **Malatesta S**, White LF, Parry CDH, Bouton TC, Ragan EJ, Horsburgh CR, Warren RM, Jacobson KR. Alcohol and Tobacco Use in a Tuberculosis Treatment Cohort during South Africaâ€™s COVID-19 Sales Bans: A Case Series. International Journal of Environmental Research and Public Health. 2021;18(10):5449. doi:10.3390/ijerph18105449
